A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
NCT06525909 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-07-29
Summary
This is a prospective, multicentre observational study of Chronic Hepatitis B (CHB)in different clinical stages. We intend to compare the immune status of various types of CHB patients, and we propose to establish a staging and grading criteria for the immune exhaustion status of patients with CHB.
Conditions
- Hepatitis B, Chronic
Sponsors & Collaborators
-
Tongji Hospital
lead OTHER
Principal Investigators
-
Qin Ning, Doctor · Department of infectious Diseases, Tongji Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-20
- Primary Completion
- 2026-12-01
- Completion
- 2028-12-10
Countries
- China
Study Locations
More Related Trials
-
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
NCT05769816 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
NCT01298037 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
NCT05661786 ·Status: RECRUITING
-
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
NCT03546530 ·Status: COMPLETED ·Phase: NA
-
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
NCT06041022 ·Status: UNKNOWN
-
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
NCT06777173 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B
NCT05905731 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion
NCT01878565 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Real-world Study Optimizing Nucleotide-analogues
NCT05937178 ·Status: RECRUITING
-
The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia
NCT05357183 ·Status: UNKNOWN
-
Research on Clinical Recovery and Maintenance Strategies for CHB
NCT06803368 ·Status: RECRUITING ·Phase: NA
-
Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy
NCT02589652 ·Status: UNKNOWN
-
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656 ·Status: RECRUITING
-
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients
NCT03777969 ·Status: ACTIVE_NOT_RECRUITING
-
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection
NCT05542979 ·Status: COMPLETED ·Phase: PHASE1
-
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
NCT04264312 ·Status: COMPLETED
-
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
NCT07146100 ·Status: RECRUITING
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
EFFicacy Optimization Research of Telbivudine Therapy
NCT00962533 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients
NCT01958229 ·Status: COMPLETED
-
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
NCT02862106 ·Status: COMPLETED ·Phase: PHASE2
-
Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy
NCT05792878 ·Status: UNKNOWN